All Posts By

Smartkarma Daily Briefs

Daily Brief ESG: Nominating Committee Also Has Problems Achieving Only Formal Criteria of Corporate Governance Code and more

By | Daily Briefs, ESG

In today’s briefing:

  • Nominating Committee Also Has Problems Achieving Only Formal Criteria of Corporate Governance Code


Nominating Committee Also Has Problems Achieving Only Formal Criteria of Corporate Governance Code

By Aki Matsumoto

  • Nominating Committee’s main activity is the selection of individual director candidates, and the Nominating Committee tends to be less involved in issues related to top management appointments, including succession planning.
  • Although most companies have a majority of independent directors as members of the nominating committee, the nominating committee may in fact be a body that approves top management’s proposals.
  • Companies focus only on prime market listing criteria of “committee establishment and committee member composition” and overlook original intent. The problem is that it’s all about achieving the formal criteria.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: ECM Weekly (16th July 2023) – LG Energy and more

By | Daily Briefs, ECM

In today’s briefing:

  • ECM Weekly (16th July 2023) – LG Energy, Socionext, Plus Alpha, Syngenta, Cinema XXI, Genda, Fadu
  • Unisound AI Technology IPO: Speech Recognition AI Unicorn And Developer of LLM UniGPT


ECM Weekly (16th July 2023) – LG Energy, Socionext, Plus Alpha, Syngenta, Cinema XXI, Genda, Fadu

By Sumeet Singh


Unisound AI Technology IPO: Speech Recognition AI Unicorn And Developer of LLM UniGPT

By Andrei Zakharov

  • Founded in 2012, Unisound AI Technology is a Beijing-based pioneer in Artificial General Intelligence (AGI). The company offers easy-to-deploy AI products and solutions in China. 
  • Unisound AI Technology seeks to raise capital for R&D activities, international expansion, and general working capital purposes. The company chose CICC and Haitong to tap capital markets with HK IPO. 
  • I like growing brand recognition, in-house 60B-parameter LLM UniGPT, high growth in the Smart Life segment, and the opportunity to sell self-developed proprietary AI chips in China.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): GEMWeekly (14 Jul 2023): China and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • GEMWeekly (14 Jul 2023): China, South Korea Macro; Alibaba, Ant, JD.com, Baidu, Foxconn, TSMC, Wipro
  • China Healthcare Weekly (Jul.14)-TCM Demand Switch, 8% Benchmark Growth Rate, GLP-1 Change Game Rule


GEMWeekly (14 Jul 2023): China, South Korea Macro; Alibaba, Ant, JD.com, Baidu, Foxconn, TSMC, Wipro

By Wium Malan, CFA


China Healthcare Weekly (Jul.14)-TCM Demand Switch, 8% Benchmark Growth Rate, GLP-1 Change Game Rule

By Xinyao (Criss) Wang

  • By comparing medical insurance expenditure and income, as well as the pharmaceutical manufacturing revenues and profits for the same period, we find something interesting. 
  • Due to COVID-19, the sales of TCM in 22Q4 and 23Q1 surged. But in 23Q2-Q4, people’s demand could change. Therefore, the performance of related TCM company would also switch. 
  • New generation weight loss drugs represented by Semaglutide would change the logic and supply-demand relationship of the entire market. This is a situation that investors need to be aware of.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Index Rebalance & ETF Flow Recap: ASX and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Index Rebalance & ETF Flow Recap: ASX, Chinext, URA, Korea Stocks, NKY
  • Last Week in Event SPACE: Celltrion, Fast Retailing, Canon, Costa, Chindata
  • EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades-Summer Lull


Index Rebalance & ETF Flow Recap: ASX, Chinext, URA, Korea Stocks, NKY

By Brian Freitas


Last Week in Event SPACE: Celltrion, Fast Retailing, Canon, Costa, Chindata

By David Blennerhassett

  • According to Invest Chosun, Celltrion Inc (068270 KS) plans to submit a merger registration statement to the KRX in July, with Mirae Asset Securities acting as the lead underwriter.
  • Fast Retailing (9983 JP) investors are in a conundrum. The stock is doing well. With one quarter to go, the company just raised its full-year EPS target by 8.3%.
  • Canon (7751 JP)‘s most recent buyback should be done now-ish. They have been ~15-20% of volume over the past month. The Trade would be short Canon vs Ricoh (7752 JP).

EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades-Summer Lull

By Simon Harris

  • Weekly summary of vol changes and moves across Global Markets
  • Analysing ATM volatility and skew changes over the last 5 days
  • We suggest a few trades to take advantage of the implied vol surfaces

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Wharf REIC 1997HK: Should We Bet on HK Luxury Retail? Lack of Catalyst & Weak Chinese Spending Power and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Wharf REIC 1997HK: Should We Bet on HK Luxury Retail? Lack of Catalyst & Weak Chinese Spending Power
  • Bank of New York Mellon Corp: Initiation of Coverage – Business Strategy & Other Drivers
  • Molson Coors Beverage Company: Initiation of Coverage – Diversification
  • State Street Corporation: Initiation of Coverage – Business Strategy & Other Drivers
  • The Allstate Corporation: Initiation of Coverage – What Is Its Biggest Competitive Advantage? Financial Forecasts


Wharf REIC 1997HK: Should We Bet on HK Luxury Retail? Lack of Catalyst & Weak Chinese Spending Power

By Jacob Cheng

  • In this insight, we conducted fundamental analysis on Wharf REIC .  It has a simple business model that it operates key malls in HK including Harbour City and Times Square
  • Macro-Wise, despite Wharf REIC should be seeing a recovery trend in terms of retail sales, the weak Chinese economy could pose concern on Wharf REIC’s retail sales
  • Wharf REIC is also facing several headwinds such as high interest cost and weak office market in Hong Kong.  We view the re-rating potential limited despite attractive valuation

Bank of New York Mellon Corp: Initiation of Coverage – Business Strategy & Other Drivers

By Baptista Research

  • This iThis is our first report on a global custodian and asset management behemoth, Bank of New York Mellon Corp.
  • This After a surge in deposit balances following recent market fluctuations, BNY Mellon finished the quarter slightly higher than its starting point.
  • The company’s broader liquidity platform, managing over $1.3 trillion of cash and short-term investments, witnessed growth in most channels.

Molson Coors Beverage Company: Initiation of Coverage – Diversification

By Baptista Research

  • This is our first report on global beverage giant, Molson Coors Beverage Company. has exhibited commendable resilience this quarter, particularly with their premium light brands in the U.S.
  • Their brands, Coors Light and Miller Lite, registered double-digit revenue growth, significantly aided by their first Super Bowl campaign in over three decades.
  • We initiate coverage on the stock of Molson Coors Beverage Company with a ‘Hold’ rating.

State Street Corporation: Initiation of Coverage – Business Strategy & Other Drivers

By Baptista Research

  • This is our first report on State Street, a prominent provider of asset servicing and other financial services in the U.S.
  • The company experienced a varied market performance in the second quarter due to continued strength in developed equity markets, weakness in emerging markets, and a subdued market environment.
  • State Street onboarded $1.2 trillion of Assets Under Custody/Administration (AUC/A) primarily through the State Street Alpha platform, underscoring its effectiveness.

The Allstate Corporation: Initiation of Coverage – What Is Its Biggest Competitive Advantage? Financial Forecasts

By Baptista Research

  • This is our first report on one of the largest insurance companies, the Allstate Corporation.
  • The company had a mediocre quarterly result and saw a 26% year-over-year increase in total revenues, totaling $13.8 billion.
  • This was fueled by a rise in premiums, investment income, and realized capital gains, with total premiums showing a 9% year-over-year growth to reach $12.5 billion, driven by growth across all segments, especially the auto insurance segment which grew 11% year over year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Equity Markets – Is Icarus Flying Too Close to the Sun? and more

By | Daily Briefs, Macro

In today’s briefing:

  • Equity Markets – Is Icarus Flying Too Close to the Sun?


Equity Markets – Is Icarus Flying Too Close to the Sun?

By Jeroen Blokland

  • Unlike headline inflation, US Core CPI will likely continue to drop in the remainder of the year, but equity markets are way ahead of themselves again.
  • Our Fear & Frenzy Sentiment Index has moved further into Frenzy territory, indicating the current rally is at imminent risk.
  • China’s economic momentum is vanishing with headline inflation at zero, while exports are down 5% from their peak, signaling the global economy will not come to the rescue.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Foxconn Industrial Internet, HDFC Bank, Cameco Corp, Liontown Resources, Eoptolink Technology Inc Ltd, RL Commercial REIT, Samsung C&T, Neuren Pharmaceuticals, Celltrion Inc and more

By | Daily Briefs, Most Read

In today’s briefing:

  • SSE50 Index Rebalance Preview: Potential Adds Powering Higher
  • Index Rebalance & ETF Flow Recap: HSCI, HSCEI, HSI, CSI300, CSI500, SSE50, HDFC Bank, Sensex
  • Solactive Global Uranium & Nuclear Components Index Rebalance Preview: Potential Changes
  • S&P/​​​​​​​​ASX Index Rebalance Preview: Potential Changes in September
  • ChiNext/​​​ChiNext50 Index Rebalance Preview: Potential Changes & Basket Performance
  • RL Commerical REIT IPO Initiation: A Big One
  • Japan Weekly | Ryohin Keikaku, Nitori, Advantest, Welcia
  • Korean Holdcos Vs Opcos Gap Trading Opportunities in 3Q 2023
  • Index Rebalance & ETF Flow Recap: ASX, Chinext, URA, Korea Stocks, NKY
  • Last Week in Event SPACE: Celltrion, Fast Retailing, Canon, Costa, Chindata


SSE50 Index Rebalance Preview: Potential Adds Powering Higher

By Brian Freitas

  • Two thirds of the way through the review period, we see 10 potential adds/8 potential deletes in December. However, there can be a maximum of 5 changes at a review.
  • We estimate a one-way turnover of 5.8% at the December rebalance leading to a one-way trade of CNY 4.67bn. Index arb balances could increase the impact on the stocks.
  • The potential adds have outperformed the potential deletes over the last six months and there has been renewed outperformance over the last month.

Index Rebalance & ETF Flow Recap: HSCI, HSCEI, HSI, CSI300, CSI500, SSE50, HDFC Bank, Sensex

By Brian Freitas


Solactive Global Uranium & Nuclear Components Index Rebalance Preview: Potential Changes

By Brian Freitas

  • Based on prices and turnover from 10 July, there could be one deletion from the index in July. Plus there will be capping and float changes.
  • There are four stocks that meet the inclusion criteria but all are non-pure play companies and the index is already at the limit of 15 non-pure play companies.
  • There will be a large impact on a lot of stocks but the flows are not very large due to the limited assets tracking the index.

S&P/​​​​​​​​ASX Index Rebalance Preview: Potential Changes in September

By Brian Freitas

  • We forecast 22 changes across the ASX50 Index, ASX100 Index, S&P/ASX 200 (AS51 INDEX) and ASX300 Index at the September rebalance.
  • Some of the changes are high probability while others are close to cutoffs. The impact of passive trading will be pretty large on a lot of stocks.
  • Short interest on the potential deletes indicates some pre-positioning but there should still be a fair bit more to do.

ChiNext/​​​ChiNext50 Index Rebalance Preview: Potential Changes & Basket Performance

By Brian Freitas

  • One third of the way through the review period, we forecast 10 changes for the ChiNext Index (SZ399006 INDEX EQUITY) and 5 changes for the ChiNext 50 Index in December.
  • Passive trackers are estimated to trade around +/-0.5 days ADV on most of the potential adds/deletes, though there are some deletes that will have over 1 day ADV to sell.
  • The potential inclusion to one or both indices have outperformed the potential deletes by a huge margin in the 5 months. We’d wait for a pullback to re-enter positions.

RL Commerical REIT IPO Initiation: A Big One

By Arun George

RL Commercial REIT (1888938D PM)/RLC REIT is the REIT platform of Robinsons Land Co (RLC PM), one of the leading property developers in the Philippines. RLC REIT has opened its books for an IPO in the Philippines to raise PHP24.4 billion ($483 million) through a secondary offering of 3.3 billion units (33.6% of outstanding units) at a maximum price of PHP7.31 per unit. The bookbuilding period will end on 20 August with pricing is set for 20 August. The official subscription period will run from 25 August to 3 September. 

RLC REIT’s portfolio consists of 14 commercial real estate assets across the Philippines with an aggregate Portfolio GLA of 425,315 sqm and an appraised value of PHP73,884 million ($1,522 million).

RLC REIT’s IPO will the third REIT listing on the PSE after Areit (AyalaLand REIT) (AREIT PM), DDMP REIT (DDMPR PM) and Filinvest REIT (FILRT PM). RLC REIT’s listing will be quickly followed by the IPO of Megaworld Real Estate Investment Trust (MREIT PM)Megaworld REIT (MREIT) IPO: At the Front of the Back Office.

On balance, we believe that RLC REIT has attractive characteristics and will be the largest REIT as measured by market cap, asset size, and geographical spread to be listed on the PSE. We will discuss valuation in our next note.


Japan Weekly | Ryohin Keikaku, Nitori, Advantest, Welcia

By Mark Chadwick

  • The focus was on the currency this week ahead of the next BOJ meeting and waning inflationary pressures in the US. 
  • Japanese stocks were basically flat. Retailers were up first announcing results – those with significant operations in China are doing very well.
  • Advantest continues to defy gravity. The stock is up 200% over the past twelve months. Think about that….a Japanese stock up 200%!

Korean Holdcos Vs Opcos Gap Trading Opportunities in 3Q 2023

By Douglas Kim

  • In this insight, we highlight the pricing gap divergences of the major Korean holdcos and opcos in 3Q 2023.
  • Of the 38 pair trades, 22 of them involved holdcos outperforming opcos YTD and 16 of them involved opcos outperforming holdcos in the same period.
  • We highlight 38 pair trades that involve Korean holdcos and opcos.

Index Rebalance & ETF Flow Recap: ASX, Chinext, URA, Korea Stocks, NKY

By Brian Freitas


Last Week in Event SPACE: Celltrion, Fast Retailing, Canon, Costa, Chindata

By David Blennerhassett

  • According to Invest Chosun, Celltrion Inc (068270 KS) plans to submit a merger registration statement to the KRX in July, with Mirae Asset Securities acting as the lead underwriter.
  • Fast Retailing (9983 JP) investors are in a conundrum. The stock is doing well. With one quarter to go, the company just raised its full-year EPS target by 8.3%.
  • Canon (7751 JP)‘s most recent buyback should be done now-ish. They have been ~15-20% of volume over the past month. The Trade would be short Canon vs Ricoh (7752 JP).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Australia: Neuren Pharmaceuticals, Kinatico and more

By | Australia, Daily Briefs

In today’s briefing:

  • Neuren Pharmaceuticals (NEU AU): Shares Roar on Expanded Global Partnership for Newly Launched Drug
  • Kinatico Ltd – Maiden FY23 Profit of $0.2m, Ahead of Forecast


Neuren Pharmaceuticals (NEU AU): Shares Roar on Expanded Global Partnership for Newly Launched Drug

By Tina Banerjee

  • Neuren Pharmaceuticals (NEU AU) announced the expansion of partnership with Acadia Pharmaceuticals for trofinetide. Acadia’s exclusive license for trofinetide in North America has been expanded to a worldwide exclusive license. 
  • Neuren is now entitled for additional payments and will receive $100M up-front, plus additional potential milestone payments of upto $427M and royalties on net sales of trofinetide outside North America.
  • Neuren has also granted Acadia an exclusive worldwide license to develop and commercialize NNZ-2591 for Rett and Fragile X syndromes and retains worldwide rights to NNZ-2591 in all other indications.

Kinatico Ltd – Maiden FY23 Profit of $0.2m, Ahead of Forecast

By Research as a Service (RaaS)

  • Kinatico Ltd (ASX:KYP) is a ‘Know Your People” regtech company providing workforce compliance monitoring and management technology and services.
  • KYP has announced in a flash update that it expects to report FY23 NPAT greater than $0.2m, marking its first profitable full year since listing.
  • This is ahead of our FY23 NPAT forecast of $0.14m. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Bangkok Chain Hospital and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Bangkok Chain Hospital (BCH TB): High COVID-Related Base Effect Impacted 1Q23 Result


Bangkok Chain Hospital (BCH TB): High COVID-Related Base Effect Impacted 1Q23 Result

By Tina Banerjee

  • In 1Q23, Bangkok Chain Hospital (BCH TB) recorded 62% YoY decline in revenue from hospital operation, dragged by 39% YoY decline in revenue from general patients (66% of total revenue).
  • COVID-19 revenue contributed 48% of revenue in 1Q22, thereby creating a high base for 1Q23. Even if we exclude COVID-19 revenue received in 1Q22, 1Q23 revenue was down 28% YoY.
  • BCH will need time to recover and record growth. Consensus expects BCH to report revenue and EPS decline of 34% and 47%, YoY, respectively in 2023.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Kum Yang, ALT Semicon, Samsung C&T and more

By | Daily Briefs, South Korea

In today’s briefing:

  • KRX’s Revised CFD Oversight Guidelines & Ongoing Suspicious Incidents
  • ALT Co IPO Bookbuilding Results Analysis
  • Korean Holdcos Vs Opcos Gap Trading Opportunities in 3Q 2023


KRX’s Revised CFD Oversight Guidelines & Ongoing Suspicious Incidents

By Sanghyun Park

  • The important point is that the regulations also incorporate a provision mandating the disclosure of the actual end traders’ identities when brokerages engage in CFD transactions disguised as proprietary trading.
  • Recent suspicious incidents raise concerns because they are carried out through brokerages’ proprietary trading practices, making them relatively more difficult for local regulatory authorities to detect and monitor.
  • We need to closely monitor the market’s abnormal volatility following the strengthened new rules on CFDs and carefully consider the setup for responding to these changes.

ALT Co IPO Bookbuilding Results Analysis

By Douglas Kim

  • ALT’s IPO price has been determined a 25,000 won, which is 22% higher than the high end of the IPO price range.
  • A total of 1,937 institutional investors participated in the IPO offering with a competition demand ratio of 1,836 to 1.
  • Our base case valuation of ALT is market cap of 299 billion won or 33,365 won per share, which represents 33% higher than the IPO price range of 25,000 won.

Korean Holdcos Vs Opcos Gap Trading Opportunities in 3Q 2023

By Douglas Kim

  • In this insight, we highlight the pricing gap divergences of the major Korean holdcos and opcos in 3Q 2023.
  • Of the 38 pair trades, 22 of them involved holdcos outperforming opcos YTD and 16 of them involved opcos outperforming holdcos in the same period.
  • We highlight 38 pair trades that involve Korean holdcos and opcos.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars